Cardiac Quality Control
Cardiac Quality Control

The Randox Acusera Tri-Level Cardiac Quality Control is designed for use in the routine monitoring of both accuracy and precision. Assayed instrument and method specific target values are provided for 7 cardiac markers along with temperature specific target values for CK and CK-MB.
Features & Benefits
- Lyophilised for enhanced stability
- Human based serum
- Assayed target values provided for 7 cardiac markers
- Cut off levels for Troponin I and T in line with internationally recommended levels
- Stable to expiry date at 2°C – 8°C
- Reconstituted stability of 5 days at 2°C – 8°C or 4 weeks at -20°C
Description | Size | Analytes | Cat No | |
---|---|---|---|---|
Tri-Level Cardiac Control | 3 x 1ml | 7 | CQ3100 | |
Tri-Level Cardiac Control | 3 x 2ml | 7 | CQ3259 | |
Analytes
- CK Total
- CK-MB (Mass)
- Myoglobin
- Troponin T
- CK-MB (Activity)
- Homocysteine
- Troponin I
Related Products
Total Antioxidant Status Quality Control

Dedicated control for use in the routine monitoring of the Randox Total Antioxidant Status assay on clinical chemistry analysers
Features & Benefits
- Lyophilised for enhanced stability
- Bovine based serum
- Stable to expiry date at 2°C – 8°C
- Reconstituted stability of 2 days at 2°C – 8°C or 12 hours at 15°C – 25°C
Description | Size | Analytes | Cat No | |
---|---|---|---|---|
Total Antioxidant Status Control | 10 x 5 ml | 1 | NX2331 | |
Analytes
- Total Antioxidant Status
Related Products
Superoxide Dismutase (Ransod) Quality Control

A dedicated Superoxide Dismutase control for use in the routine monitoring of the Randox Ransod assay on clinical chemistry analysers.
Features & Benefits
- Lyophilised for enhanced stability
- Bovine based whole blood
- Stable to expiry date at 2°C – 8°C
- Reconstituted stability of 10 days at 2°C – 8°C
Description | Size | Analytes | Cat No | |
---|---|---|---|---|
Ransod (superoxide dismutase) | 10 x 1 ml | 1 | SD126 | |
Analytes
- Superoxide Dismutase
Glutathione Peroxidase (Ransel) Quality Control

A dedicated Glutathione Peroxidase control for use in the routine monitoring of the Randox Ransel assay on clinical chemistry analysers.
Features & Benefits
- Lyophilised for enhanced stability
- Bovine based whole blood
- Stable to expiry date at 2°C – 8°C
- Reconstituted stability of 3 days at 2°C – 8°C
Description | Size | Analytes | Cat No | |
---|---|---|---|---|
Ransel (glutathione peroxidase) control | 10 x 1 ml | 1 | SC692 | |
Analytes
- Glutathione Peroxidase
Glutathione Reductase Quality Control

A dedicated Glutathione Reductase control for use in the routine monitoring of the Randox Glutathione Reductase assay on clinical chemistry analysers.
Features & Benefits
- Lyophilised for enhanced stability
- Bovine based serum
- Stable to expiry date at 2°C – 8°C
- Reconstituted stability of 1 day at 2°C – 8°C or 8 hours at 15°C – 25°C
Description | Size | Analytes | Cat No | |
---|---|---|---|---|
Glutathione Reductase Control | 10 x 5ml | 1 | GR2608 | |
Analytes
- Glutathione Reductase
Related Products
Blood Gas Quality Controls

The Randox Acusera Blood Gas Quality Controls contain assayed target values for ten parameters, covering pH, pCO2, pO2, electrolytes, glucose and lactate. The material is provided in easy to open ampoules for added convenience and ease-of-use. The liquid ready-to-use nature of the control makes it ideal for use in point-of-care testing and on a wide range of blood gas instruments.
Features & Benefits
- Liquid ready-to-use
- Aqueous material
- Method specific target values provided for the most common blood gas analysers
- Suitable for use in POC testing
- Stable to expiry date at 2°C – 8°C
- Once opened controls should be analysed immediately for pH and blood gas parameters, for electrolyte measurements the control should be analysed within 1 hour of opening
Description | Size | Analytes | Cat No | |
---|---|---|---|---|
Blood Gas Control Level 1 | 30 x 1.8ml | 10 | BG5001 | |
Blood Gas Control Level 2 | 30 x 1.8ml | 10 | BG5002 | |
Blood Gas Control Level 3 | 30 x 1.8ml | 10 | BG5003 | |
Analytes
- pCO2
- pO2
- Calcium
- Glucose
- Potassium
- pH
- Bicarbonate
- Chloride
- Lactate
- Sodium
Related Products
Lipid Quality Controls
Our Acusera Lipid Quality Controls have been manufactured from 100% human serum to ensure they are commutable, mirroring the behaviour of a real patient sample, with minimal lot to lot value shifts. As all of our lipid quality controls are lyophilised, they contain no stabilisers or preservatives which are known to affect the overall performance of the controls. The multi-analyte controls enable test menu consolidation which, along with the four year shelf life from the date of manufacture, ensures minimal waste helping your lab reduce costs.
Lyophilised Lipid Quality Controls
Haematology Quality Control

Combining 45 analytes in total the Randox Acusera Haematology quality control completely covers the commonly tested full blood profile in a single control. Providing a true third party solution for Sysmex and Mindray haematology analysers with 5-part differential technology an unbiased, independent assessment of analytical performance is guaranteed.
Features & Benefits
- Liquid ready-to-use
- 100% Human whole blood
- Barcoded labels enabling quick and easy sample recognition
- Stable for 70 days at 2ºC to 8°C
- Open vial stability of 14 days at 2ºC to 8°C
Description | Size | Analytes | Cat No | |
---|---|---|---|---|
Haematology Tri-Level | 3 x 2 x 4.5 ml | 45 | HM5162 | |
Analytes
- Basophils (BASO)*
- % Basophils (% BASO)
- BASO-X
- BASO –Y
- DIFF-X
- DIFF-Y
- Eosinophils (EOS)
- % Eosinophils (%EOS)
- FSC-X
- Haematocrit (HCT)
- Haemoglobin (HGB)
- Haemopioetic Progenitor Cell (HPC)
- IMIDC
- IMIRF
- Immature Granulocytes (IG)
- % Immature Granulocytes (%IG)
- Immature Myeloid Information (IMI)
- Immature Platelet Fraction (IPF)
- Lymphocytes (LYMPH)
- % Lymphocytes (% LYMPH)
- Mean Corpuscular Volume (MCV)
- Mean Corpuscular Haemoglobin (MCH)
- Mean Corpuscular Haemoglobin Concentration (MCHC)
- Mean Platelet Volume (MPV)
- Monocytes (MONO)
- % Monocytes (% MONO)
- Neutrophils (NEUT)
- % Neutrophils (% NEUT)
- Nucleated Red Blood Cells X (NRBC-X)
- Nucleated Red Blood Cells Y (NRBC-Y)
- Nucleated Red Blood Cells (NRBC)*
- % Nucleated Red Blood Cells (%NRBC)
- Platelet Distribution Width (PDW)
- Platelet Large Cell Ratio (P-LCR)
- Plateletcrit (PCT)
- Platelets (PLT)
- Platelets Optical Count (PLT-0)
-
Red Blood Cells (RBC)
- Red Blood Cell X (RBC-X)
- Red Blood Cell Y (RBC-Y)
- Red Blood Cell Distribution Width CV (RDW-CV)
- Red Blood Cell Distribution Width SD (RDW-SD)
- Red Blood Cells Optical Count (RBC-O)
- White Blood Cells (WBC)
- White Blood Cells Differential (WBC-D)
*This product may not be suitable for the control of NRBC# and Basophils on some Sysmex models
Coagulation Quality Control

The Randox Acusera Coagulation Quality Control covers 16 analytes in total including a wide variety of factor assays, basic coagulation and thrombophilia parameters. As an assayed control instrument and method specific target values and ranges are provided.
Features & Benefits
- Lyophilised for enhanced stability
- 100% human plasma
- Assayed target values provided for 16 analytes
- Stable to expiry date at 2°C – 8°C
- Reconstituted stability of up to 24 hours at 2°C – 8°C
Description | Size | Analytes | Cat No | |
---|---|---|---|---|
Coagulation Control Level 1 | 12 x 1ml | 16 | CG5021 | |
Coagulation Control level 2 | 12 x 1ml | 16 | CG5022 | |
Coagulation Control Level 3 | 12 x 1ml | 16 | CG5023 | |
Analytes
- Prothrombin Time
- Activated Partial Thromboplastin Time
- Thrombin Time
- Fibrinogen
- Antithrombin III
- Factor II
- Factor V
- Factor VII
- Factor VIII
- Factor IX
- Factor X
- Factor XI
- Factor XII
- Plasminogen
- Protein C
- Protein S
Randox launches White Paper on Quality Control in POCT
Randox has launched the first in a series of White Papers, focusing on the importance of quality control in point-of-care testing (POCT). The White Paper is free to download and will help laboratories define an appropriate QC procedure for all POCT devices.
Patient testing at the point-of-care has increased dramatically in recent years, as technology makes it more convenient to test patient samples at the bedside producing rapid results and allowing immediate action. However, the benefits of this are only true if the results are both accurate and reliable, making quality control vitally important in the POC setting, just as it is in the laboratory.
A recent survey* identified that POCT is the largest source of error when compared to other sources of laboratory testing errors. Furthermore, the most common phase for errors in POCT is in the analytical stage, whereas in laboratory-based testing this is the least common source for errors. This highlights how vital it is to have a robust QC procedure in place for POCT as the potential risk of harm to a patient appears to be far greater for POC tests compared to those performed in a laboratory.
The White Paper from Randox covers the fundamentals of developing a POCT QC strategy in line with ISO15189 requirements, looking at who is responsible for QC, what QC is appropriate for different types of POC devices and tips for choosing IQC material and an EQA scheme.
The Paper can be downloaded from the Randox website here.
Randox second White Paper, which studies the importance of using 100% human serum controls to avoid lot-to-lot variations in immunoassay testing, will be available in December.
